Cwm LLC Has $3.78 Million Position in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Cwm LLC boosted its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 95.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 146,071 shares of the company’s stock after acquiring an additional 71,459 shares during the quarter. Cwm LLC’s holdings in Establishment Labs were worth $3,782,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of the business. Kornitzer Capital Management Inc. KS boosted its stake in shares of Establishment Labs by 26.3% in the 4th quarter. Kornitzer Capital Management Inc. KS now owns 389,160 shares of the company’s stock valued at $10,075,000 after purchasing an additional 81,155 shares in the last quarter. Adage Capital Partners GP L.L.C. boosted its stake in shares of Establishment Labs by 17.2% in the 3rd quarter. Adage Capital Partners GP L.L.C. now owns 80,000 shares of the company’s stock valued at $3,926,000 after purchasing an additional 11,736 shares in the last quarter. Assenagon Asset Management S.A. boosted its stake in shares of Establishment Labs by 357.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 30,247 shares of the company’s stock valued at $783,000 after purchasing an additional 23,639 shares in the last quarter. Legato Capital Management LLC boosted its stake in shares of Establishment Labs by 63.1% in the 4th quarter. Legato Capital Management LLC now owns 8,438 shares of the company’s stock valued at $218,000 after purchasing an additional 3,263 shares in the last quarter. Finally, Bamco Inc. NY boosted its stake in shares of Establishment Labs by 29.0% in the 3rd quarter. Bamco Inc. NY now owns 333,777 shares of the company’s stock valued at $16,378,000 after purchasing an additional 75,000 shares in the last quarter. Institutional investors and hedge funds own 72.91% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on ESTA shares. Citigroup upped their price target on shares of Establishment Labs from $49.00 to $60.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Stephens reiterated an “overweight” rating and set a $47.00 price target on shares of Establishment Labs in a research report on Thursday, January 11th. Mizuho upped their price target on shares of Establishment Labs from $50.00 to $65.00 and gave the stock a “buy” rating in a research report on Monday, April 1st. Finally, JPMorgan Chase & Co. upped their price target on shares of Establishment Labs from $46.00 to $53.00 and gave the stock an “overweight” rating in a research report on Thursday, February 29th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $55.00.

Establishment Labs Price Performance

Shares of NASDAQ:ESTA opened at $48.95 on Thursday. Establishment Labs Holdings Inc. has a 1-year low of $16.96 and a 1-year high of $74.58. The company has a debt-to-equity ratio of 10.26, a current ratio of 3.06 and a quick ratio of 1.67. The business has a 50-day moving average price of $47.78 and a two-hundred day moving average price of $36.44.

Establishment Labs (NASDAQ:ESTA) last announced its quarterly earnings data on Wednesday, February 28th. The company reported ($0.79) earnings per share for the quarter, topping the consensus estimate of ($0.95) by $0.16. The firm had revenue of $31.60 million during the quarter, compared to analysts’ expectations of $31.44 million. Establishment Labs had a negative return on equity of 357.81% and a negative net margin of 47.53%. The company’s quarterly revenue was down 27.9% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.55) EPS. On average, equities research analysts expect that Establishment Labs Holdings Inc. will post -1.58 earnings per share for the current year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.